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Abstract
Rodents, particularly the mouse, have been used extensively for genetic modeling and 
analysis of human chromosomal alterations based on the syntenic conservations between 
the human and rodent genomes. In this article, we will discuss the emergence of CRISPR/
Cas9-facilitated chromosome engineering techniques, which may open up a new avenue 
to study human diseases associated with chromosomal abnormalities, such as Down syn-
drome and cancer.
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1. Introduction
Chromosomal alterations are a major cause of human disease. The presence of an extra copy of 
human chromosome 21 (Hsa21) leads to Down syndrome (DS). Due to the evolutionary conserva-
tion, orthologous regions of Hsa21 have been found in a limited number of discrete chromosomal 
segments in the genomes of other mammals, including mice and rats (Figure 1). These shared 
syntenies provide a treasure trove for genetic modeling as well as the mechanistic dissection of 
DS. The first rodent model generated for DS was a mutant mouse that carried an extra copy of 
mouse chromosome 16 (Mmu16), where many Hsa21 gene orthologs are located in this genomic 
region. However, given that the mouse was embryonic lethal, many groups soon turned their 
attention to the postnatally viable Ts65Dn mouse line, which carries an unbalanced derivative of 
an irradiation-induced translocation, Ts(1716)65Dn [1]. This extra chromosome contains the entire 
genomic region distal to Mir155 on Mmu16 and a subcentromeric region on Mmu17, which is not 
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
syntenic to Hsa21. Another attractive mouse model used by DS researchers is the transchromo-
somal strain, Tc1 [2], which carries a Hsa21. However, because Hsa21 was irradiated while being 
transferred to mouse ES cells through cell fusion, the Hsa21 in Tc1 mice carries several unde-
sired genetic rearrangements, including deletions, duplications, and other rearrangements. Both 
Ts65Dn and Tc1 mice have been extensively characterized and show several phenotypic features 
similar to human DS despite the presence of secondary molecular aberrations [3]. In the recent 
years, the numbers of mouse mutants carrying rearranged Hsa21 syntenic regions has increased 
significantly due to the development of Cre/loxP-mediated chromosome engineering techniques. 
The most genetically accurate model among them is the line carrying triplications spanning the 
entirety of all Hsa21 syntenic regions, Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+  [4]. Phenotypic 
Figure 1. Schematic representation of Hsa21 and the syntenic regions on Mmu10, Mmu16, Mmu17, rat chromosome 11 
(Rno11), and Rno20.
Advances in Research on Down Syndrome4
characterizations of  this mutant revealed several  important DS-related phenotypes,  including 
heart defects and impaired cognitive function. Other engineered mouse mutants, which carry 
a triplication or deficiency of smaller Hsa21 syntenic regions [5, 6], have facilitated systematic 
genetic dissections of DS phenotypes. With the emergence of CRISPR/Cas9-facilitated genome 
editing, attempts have been made to further improve the efficiency of mammalian chromosome 
manipulations, whether it be deletions, duplications, inversions, or translocations [7–10], includ-
ing those in Hsa21 syntenic regions.
2. The potential advantages of CRISPR/Cas9-facilitated chromosome 
engineering
Chromosome engineering enables the generations of deletions, duplications, inversions, and 
translocations in a particular genome of interest, which in turn are used as research tools for 
the genetic modeling and dissection of human diseases and disorders caused by chromosomal 
alterations. These models act as invaluable resources for researchers, aiding in the identification 
of causative genes and cellular mechanisms that underlie the presentation of clinical phenotypes 
associated with these genomic abnormalities, such as in DS. Using traditional Cre/loxP-mediated 
ES cell-based chromosome engineering approaches to generate chromosomal alterations 
requires a multistep process [11]. Such ES cells are limited to a few strains of mice, such as 129S5, 
and are not available for other rodent species, including rats. The most popular ES cell-based 
chromosome engineering procedure requires the use of ES cells carrying a null allele of Hprt.
For the aforementioned reasons, CRISPR/Cas9 may have the potential to play an important 
role in mammalian chromosome engineering, which complements the current approach. 
Specifically, it may offer opportunities to obtain mutants for other less commonly used ani-
mal models by direct zygote injection of the CRISPR/Cas9 components without involving ES 
cells [12–14]. This new approach may also facilitate chromosome engineering in mice from 
different  strain backgrounds  than  those currently available with  the Cre/loxP-mediated ES 





chromosomal rearrangements, the same cannot be said for CRISPR/Cas9-facilitated chromo-
some engineering. Current data have not provided sufficient evidence to draw such a conclu-
sion [7–9]. On the other hand, current data do suggest that chromosomal location and/or the 
endpoints of  the  fragment manipulated  through CRISPR/Cas9  can  influence  the  efficiency 
of genome engineering. In Table 1, the size of both the Nox4-Grm5 and Runx1-Cbr1 region is 
around 1.1 Mb; however, the efficiencies of generating F0 deletion mouse were 30 and 3%, 
respectively. Kraft  et  al.  [9]  also discovered  the  efficiency  is variable  among different  loci. 
In addition, Boroviak et al. [8] concluded that the efficiencies of deletions and inversion are 
similar in their studies from Nox4, Grm5, and Nox4-Grm5 (Table 1). However, recent results 
showed the inversion efficiency is lower than deletion in both mice and rats (Table 1) [7].
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3. General CRISPR/Cas9-facilitated chromosome engineering 
components
The CRISPR/Cas9 system consists of three basic components: (1) CRISPR RNA (crRNA), guid-
ing Cas9 complex to the target sequence; (2) trans-activating crRNA (tracrRNA), hybridizing 
with crRNA for Cas9 complex targeting; and (3) Cas9 endonuclease, cleaving target double-
strand DNA. The damaged DNA will be recognized and repaired in two manners: nonhomol-
ogous end joining (NHEJ) and homology-directed repair (HDR) (Figure 2) [15, 16]. Besides 
the aforementioned, there are other considerations that should be noted when designing the 
CRISPR/Cas9-related experiments, such as the use of bridge sequence, choosing between 
direct ES cell or zygote injection, and the genotyping strategies through PCR primer designs.
3.1. CRISPR/Cas9 components: guide RNA
To expedite CRISPR/Cas9-facilitated genome manipulation, several groups initially developed 
a chimeric single guide RNA containing both the crRNA and traccrRNA (sgRNA) [15, 16]. Due 
to its convenience, the sgRNA has now become the most extensively used RNA template for 
CRISPR/Cas9-based editing. The sgRNA contains a RNA scaffold with a pre-designed 20 bp 
RNA sequence, which can bind to the region of interest. Cas9 endonuclease is directed by 




erating structural variants. It was found by Boroviak et al. [8] that additional double-strand 
breaks at each endpoint would elevate the frequency of generating structural variants. First, 
they designed a set of two sgRNAs (2-sgRNA set) for each endpoint that are within 50–200 bp 




Region of interest Tyr (Exon1-2) Tyr Nox4 Grm5 Nox4-Grm5 Hmgn1 Tiam1 Runx1-Cbr1
Fragment size 9.4 kb* 65 kb 155 kb 545 kb 1.15 Mb 16.8 kb 226 kb 1.1 Mb
F0-deletion 10% 16% 24% 18% 30% 50% 19.5% 3%***
F0-inversion 30% 18% 21% 0% 0% 3%
F0-duplication 2% 1% 0% 0% 2.4%** 0%***
*Two sgRNAs were used here while all others use four sgRNAs (two 2-sgRNA sets) for the experiments.
**F1 mouse carries duplication detected by droplet digital PCR (ddPCR), although it is not detected in F0 mouse.
***One mouse with duplication and deletion was obtained from a second round of microinjection.
Table 1. Percentage of the rearranged alleles among different loci after CRISPR/Cas9-facilitated chromosome engineering.
Advances in Research on Down Syndrome6
endpoint, and the deletion efficiency was found to be 10%, but the frequency of a 65 kb dele-
tion at the same genomic region was increased to 16% when four sgRNAs, with a 2-sgRNA 
set at each endpoint, were used (see Table 2). Boroviak et al. [8] attributed the increase in effi-
ciency to extend the temporal window of DNA breaks before repairing, which provides more 
opportunities for complete cycles of error-prone repair, and thus resulting in chromosome 
rearrangement. Birling et al. also believed a 2-sgRNA set at each endpoint would increase the 
probability of obtaining double-strand breaks [17]. They implemented this strategy to obtain 
large structural variations in mice and rats using a 2-sgRNA set at each endpoint with a dis-
tance of less than 150 bp between the two sgRNAs.
Although  sgRNAs have been widely utilized,  it  is  still  controversial whether  the  cleavage 
efficiency  of  sgRNA  is  comparable  to  those  of  dual-crRNA:tracrRNA.  Unlike  sgRNA,  in 
dual-crRNA:tracrRNA, crRNA and tracrRNA are synthesized separately, and then annealed 
together to be used as the guide RNA [15, 18, 19]. Recently, a few reports have demonstrated 
that  a  dual-crRNA:tracrRNA  combined  with  Cas9  protein  can  increase  the  efficiency  of 
genome editing, especially the frequency of HDR [18–20]. Therefore, dual-crRNA:tracrRNA 
should still be considered when planning chromosome rearrangement projects.
Figure 2. Two types of DNA repairs occur in vivo  after  double-strand  breaks  caused  by  Cas9  endonuclease.  DSB, 
double-strand break; crRNA, CRISPR RNA; tracrRNA, trans-activating crRNA; HDR, homology-directed repair; NHEJ, 
nonhomologous end joining.
Organism Mice
Region of interest Tyr (Exon1-2) Tyr Nox4 Grm5 Nox4-Grm5
Fragment size 9.4 kb* 65 kb 155 kb 545 kb 1.15 Mb
F0-deletion 10% 16% 24% 18% 30%
Imprecise deletion 10% 12% 15% 15% 13%
Precise deletion 0% 4% 9% 3% 17%
*Two sgRNAs were used here while all others use four sgRNAs (two 2-sgRNA sets) for the experiments.
Table 2. Percentage of the precise deletion and imprecise deletion after the introduction of the bridging sequence.
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3.2. CRISPR/Cas9 components: Cas9
So far, most of the rodent models with engineered chromosomes have been produced via a 
one-time injection of Cas9 mRNA and guide RNAs into the zygote cytoplasm. Based on the 
current  literature, 10–200 ng/μl of Cas9 mRNA seems  to be sufficient  to generate chromo-
some  rearrangements  [7, 8]. This approach is both fast and robust, but carries with it the 
potential complication of genetic mosaicism [21], which may result in different cell popula-
tions in F0 founder animals carrying different mutations [8, 22]. For example, up to six dif-
ferent alleles from one single founder have been detected by Birling et al. [17]. Boroviak et al. 
[8] also showed that many F0 founder mice were genetically mosaic, with up to 4–5 alleles 
detected. The genetic mosaicism may be due to two possibilities, one being that Cas9 mRNA 
must first be translated prior to cleavage of the double-strand DNA; however, transcription 
and translation activity is suppressed in the mouse zygote and de novo translation of Cas9 
mRNA might be delayed until second cell stage [21, 23]. The second possibility might be that 
the functionality of Cas9 and its guide RNA may linger into the 2–4 cell stage and beyond. 
Likewise,  injection of a vast excess of guide RNAs and Cas9 mRNA may result  in  repeat-
ing the cleavage-repair cycles until the targeting site is destroyed by an insertion or deletion 
(INDEL) or a structural variant [8]. Therefore, zygote injection of Cas9 protein instead of the 




Double-strand DNA  breaks  produced  by  Cas9  endonuclease  are  repaired  by  two major 
pathways: nonhomologous DNA end joining (NHEJ) and homolog-directed repair (HDR) 
(Figure 2). NHEJ is error-prone and often leads to unpredictable insertions and deletions 
(INDELs), while HDR  introduces  precise  genetic modification when  a  template DNA  is 
available  [28, 29]. As  those unpredictable  INDELs might bring out unexpected effects on 
cells, it is desirable to generate structural variations with nucleotide precision through 
HDR  to  repair double-strand DNA breaks. Boroviak  et  al.  [8] established mouse models 
of deletions with precise endpoints by providing a single strand oligonucleotide DNA as 
repair template. These oligonucleotides were 120 bp in length and were designed to bridge 
the deletion juncture. The sequence was designed directly adjacent to the most external 
guide RNA site but omitting the Cas9 cleavage sites  to avoid repeated CRISPR/Cas9 cut-
ting. Boroviak et al. [8] reported a total of 17 out of 53 (32%) deletion mice were born with a 
precise deletion juncture (Table 2).
3.4. Via ES cell manipulation or direct zygote microinjection
Two routes have been used to establish rodent models using CRISPR/Cas9-facilitated chromo-
some engineering: (1) those produced through transfection of expression vectors containing 
guide RNAs and Cas9 into embryonic stem cells (ESCs) [9] and (2) models obtained directly 
from fertilized zygotes injected with guide RNAs and Cas9 mRNA [7, 8].
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Kraft et al.  [9] introduced the process of using CRISPR/Cas9 technology for generation of 
structural variations in mouse ESCs. They successfully generated genomic rearrangements 
across  intervals  spanning  from  1  kb  to  1.6  Mb  and  later  showed  germline  transmission 







appeared less robust when compared to the generation of deletions and inversions. One of 
the possible reasons is two homologs of the affected chromosome may be involved in genera-
tion of a duplication.
3.5. Genotyping strategy for identifying chromosomal structural variations
With these new genetic engineering methods, standard PCR is still primarily the method of 
choice to  identify the structural variants no matter if  in ES cell clones or founder mice and 
rats using CRISPR/Cas9. Since all three types of structural variants, deletion, inversion, and 
duplication, result in the alteration of the junction region, the approach based on PCR mainly 
focused on detecting the fragment around the breakpoints in those chromosomes. Selections 
of appropriate PCR primers are a crucial factor to successfully detect and distinguish different 
DNA structural variants. The strategy of designing primers is shown in Table 3. Usually prim-
ers are designed near but outside the areas targeted by guide RNAs or 2 guide RNA sets at 
each endpoint of the rearrangement fragment. The primer sets near the Cas9 cleavage sites at 
the head (proximal endpoint closer to the centromere) of the region of interest, forward primer 
1 (F1) and reverse primer 1 (R1), and the primer sets at the tail (distal endpoint further from 
the centromere) of the region of the interest, forward primer 2 (F2), and reverse primer 2 (R2), 
can be used to identify upstream and downstream double-strand breaks [7]. Different combi-
nations of primers located at proximal and distal ends of the region are required to recognize 
the structural variation junctions [8]. The combinations are shown in Table 3. F1 + R2 primer 
sets are utilized for deletion analysis, while F1 + F2 and R1 + R2 are for inversion breakpoints. 
For duplication  characterization, different primer  sets might  be used  to distinguish differ-
ent possibilities. If combining with other primer sets, the direction of the duplication in the 
genome can be determined. (1) F1 + R1 & F2 + R1 & F2 + R2 could identify the duplication with 
head-to-tail and head-to-tail orientation as shown in Table 3, Dup1. (2) F1 + F2 & R1 + F2 & 
R1 + R2 primer sets could detect the duplication with tail-to-head and tail-to-head orientation 
as shown in Table 3, Dup2. (3) F1 + F2 & R1 + R1 & F2 + R2 sets could detect the duplication 
with tail-to-head and head-to-tail orientation as shown in Table 3, Dup3. (4) F1 + R1 & F2 + F2 & 
R1 + R2 sets could detect the duplication with head-to-tail and tail-to-head orientation as 
shown in Table 3, Dup4.
PCR assay is convenient, but it may not be able to reveal extensive information on the chro-
mosome rearrangements. Boroviak et al. [8] reported that in some cases, only one end of the 
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inversion could be detected rather than two ends. Birling et al. [17] also mentioned that dele-
tion of Dyrk1a region in rats cannot be detected by standard PCR, but they discovered 4 
founder rats carried one copy of Dyrk1a gene through droplet digital PCR (ddPCR). These 
false negative results indicated the junction areas may be changed during DNA cleavage and 
repair; therefore, it stops the primer from binding to the expected site. Thus, other approaches 
need to be considered to complement standard PCR for identifying structural variations when 
using CRIPSR/Cas9 system. For example, ddPCR and real-time PCR can be utilized for deter-
mining copy number variants in genome.
4. Summary
With the addition of the techniques of CRISPR/Cas9-facilitated chromosome engineering 
beyond the current tools, it is reasonable to predict that many important insights of DS will 
be revealed in the near future, which will surely be a welcome news since they may be instru-





Del, deletion; Dup, duplication; F1, forward primer 1; F2, forward primer 2; Inv, inversion; R1, reverse primer 1; R2, 
reverse primer 2.
Table 3. PCR strategies for identifying the rearranged alleles after CRISPR/Cas9-facilitated recombination.
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